Access to new drugs for rare disorders in Canada.
| Autor: | Rawson NS; Pharmaceutical policy researcher, Eastlake Research Group, Oakville, Ont., and Fraser Institute, Vancouver, BC., Adams J; Cofounder, president and CEO, Canadian PKU and Allied Disorders Inc., Toronto, Ont., and Best Medicines Coalition, Toronto, Ont. |
|---|---|
| Jazyk: | angličtina |
| Zdroj: | CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne [CMAJ] 2018 Jul 09; Vol. 190 (27), pp. E840. |
| DOI: | 10.1503/cmaj.69340 |
| Abstrakt: | Competing Interests: Competing interests: None declared. |
| Databáze: | MEDLINE |
| Externí odkaz: |
|